Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 514

1.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

2.

Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype.

Alfayez M, Wang SA, Bannon SA, Kontoyiannis DP, Kornblau SM, Orange JS, Mace EM, DiNardo CD.

Leuk Lymphoma. 2019 Jan 16:1-9. doi: 10.1080/10428194.2018.1551535. [Epub ahead of print]

PMID:
30648453
3.

Rhodotorula infection in haematological patient: Risk factors and outcome.

Potenza L, Chitasombat MN, Klimko N, Bettelli F, Dragonetti G, Del Principe MI, Nucci M, Busca A, Fracchiolla N, Sciumè M, Spolzino A, Delia M, Mancini V, Nadali GP, Dargenio M, Shadrivova O, Bacchelli F, Aversa F, Sanguinetti M, Luppi M, Kontoyiannis DP, Pagano L.

Mycoses. 2019 Mar;62(3):223-229. doi: 10.1111/myc.12875. Epub 2018 Dec 28.

PMID:
30525252
4.

Author Correction: Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species.

Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SSM, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P, Pontikoglou C, Papadaki HA, Tzardi M, Belle V, Etienne E, Beauvais A, Samonis G, Kontoyiannis DP, Andreakos E, Bruno VM, Ibrahim AS, Chamilos G.

Nat Commun. 2018 Nov 22;9(1):5015. doi: 10.1038/s41467-018-07301-y.

5.

Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.

Wurster S, Lewis RE, Albert ND, Kontoyiannis DP.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01896-18. doi: 10.1128/AAC.01896-18. Print 2019 Feb.

PMID:
30455245
6.
7.

Nivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin's disease.

De la Hoz A, Foolad F, Gallegos C, Kornblau S, Kontoyiannis DP.

Bone Marrow Transplant. 2018 Oct 15. doi: 10.1038/s41409-018-0363-6. [Epub ahead of print] No abstract available.

PMID:
30323308
8.

Invasive fungal disease and cytomegalovirus infection: is there an association?

Yong MK, Slavin MA, Kontoyiannis DP.

Curr Opin Infect Dis. 2018 Dec;31(6):481-489. doi: 10.1097/QCO.0000000000000502.

PMID:
30299361
9.

Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.

DiPippo AJ, Rausch CR, Kontoyiannis DP.

Mycoses. 2019 Jan;62(1):81-86. doi: 10.1111/myc.12851. Epub 2018 Oct 24.

PMID:
30230043
10.

Recent advances in the molecular diagnosis of mucormycosis.

Dadwal SS, Kontoyiannis DP.

Expert Rev Mol Diagn. 2018 Oct;18(10):845-854. doi: 10.1080/14737159.2018.1522250. Epub 2018 Sep 19.

PMID:
30203997
11.

Immunosuppressed Adult Zebrafish Model of Mucormycosis.

Tatara AM, Wurster S, Lockworth CR, Albert ND, Walsh TJ, Mikos AG, Eisenhoffer GT, Kontoyiannis DP.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00698-18. doi: 10.1128/AAC.00698-18. Print 2018 Nov. No abstract available.

PMID:
30150461
12.

Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia.

Lacourt TE, Kavelaars A, Ohanian M, Shah ND, Shelburne SA, Futreal A, Kontoyiannis DP, Heijnen CJ.

Oncotarget. 2018 Jul 27;9(58):31244-31252. doi: 10.18632/oncotarget.25787. eCollection 2018 Jul 27.

13.

Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species.

Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SSM, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P, Pontikoglou C, Papadaki HA, Tzardi M, Belle V, Etienne E, Beauvais A, Samonis G, Kontoyiannis DP, Andreakos E, Bruno VM, Ibrahim AS, Chamilos G.

Nat Commun. 2018 Aug 20;9(1):3333. doi: 10.1038/s41467-018-05820-2. Erratum in: Nat Commun. 2018 Nov 22;9(1):5015.

14.

Therapy of Mucormycosis.

Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP.

J Fungi (Basel). 2018 Jul 31;4(3). pii: E90. doi: 10.3390/jof4030090. Review.

15.

A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae.

Castillo P, Wright KE, Kontoyiannis DP, Walsh T, Patel S, Chorvinsky E, Bose S, Hazrat Y, Omer B, Albert N, Leen AM, Rooney CM, Bollard CM, Cruz CRY.

Mol Ther Methods Clin Dev. 2018 Mar 14;9:305-312. doi: 10.1016/j.omtm.2018.03.003. eCollection 2018 Jun 15.

16.

Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes.

Fernández-Cruz A, Magira E, Heo ST, Evans S, Tarrand J, Kontoyiannis DP.

J Clin Microbiol. 2018 Sep 25;56(10). pii: e00962-18. doi: 10.1128/JCM.00962-18. Print 2018 Oct.

PMID:
30021823
17.

Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre.

Magira EE, Jiang Y, Economides M, Tarrand J, Kontoyiannis DP.

Mycoses. 2018 Nov;61(11):861-867. doi: 10.1111/myc.12830. Epub 2018 Aug 1.

PMID:
30015364
18.

Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia.

Strati P, Gabutti C, Thompson PA, Kontoyiannis DP, Ferrajoli A.

Leuk Lymphoma. 2018 Jun 18:1-3. doi: 10.1080/10428194.2018.1474527. [Epub ahead of print] No abstract available.

PMID:
29911929
19.

Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.

Lionakis MS, Lewis RE, Kontoyiannis DP.

Clin Infect Dis. 2018 Oct 30;67(10):1621-1630. doi: 10.1093/cid/ciy473.

PMID:
29860307
20.

Calcium sequestration by fungal melanin inhibits calcium-calmodulin signalling to prevent LC3-associated phagocytosis.

Kyrmizi I, Ferreira H, Carvalho A, Figueroa JAL, Zarmpas P, Cunha C, Akoumianaki T, Stylianou K, Deepe GS Jr, Samonis G, Lacerda JF, Campos A Jr, Kontoyiannis DP, Mihalopoulos N, Kwon-Chung KJ, El-Benna J, Valsecchi I, Beauvais A, Brakhage AA, Neves NM, Latge JP, Chamilos G.

Nat Microbiol. 2018 Jul;3(7):791-803. doi: 10.1038/s41564-018-0167-x. Epub 2018 May 30.

PMID:
29849062
21.

Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.

Rausch CR, DiPippo AJ, Bose P, Kontoyiannis DP.

Clin Infect Dis. 2018 Oct 30;67(10):1610-1613. doi: 10.1093/cid/ciy406.

PMID:
29771293
22.

How to prophylax against invasive fungal infections in adult ALL? An unmet need.

Cornely OA, Kontoyiannis DP.

Mycoses. 2018 Apr 25. doi: 10.1111/myc.12786. [Epub ahead of print]

PMID:
29693737
23.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

24.

Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities.

Rausch CR, Kontoyiannis DP.

J Oncol Pharm Pract. 2018 Jan 1:1078155218762624. doi: 10.1177/1078155218762624. [Epub ahead of print]

PMID:
29554829
25.

Advances in the diagnosis and treatment of fungal infections of the CNS.

Schwartz S, Kontoyiannis DP, Harrison T, Ruhnke M.

Lancet Neurol. 2018 Apr;17(4):362-372. doi: 10.1016/S1474-4422(18)30030-9. Epub 2018 Feb 21. Review.

PMID:
29477506
26.

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.

Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR 3rd, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM 3rd, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM.

Clin Infect Dis. 2018 May 17;66(11):1678-1686. doi: 10.1093/cid/cix1095.

PMID:
29438475
27.

Associations of inflammation with symptom burden in patients with acute myeloid leukemia.

Lacourt TE, Kavelaars A, Galloway-Peña JR, Sahasrabhojane PV, Shah ND, Futreal A, Kontoyiannis DP, Shelburne SA, Heijnen CJ.

Psychoneuroendocrinology. 2018 Mar;89:203-208. doi: 10.1016/j.psyneuen.2018.01.018.

PMID:
29414033
28.

The Candida auris Alert: Facts and Perspectives.

Lamoth F, Kontoyiannis DP.

J Infect Dis. 2018 Jan 30;217(4):516-520. doi: 10.1093/infdis/jix597. No abstract available.

PMID:
29390110
29.

Reply to Bazaz and Denning.

Chamilos G, Lionakis MS, Kontoyiannis DP.

Clin Infect Dis. 2018 Jun 18;67(1):157-159. doi: 10.1093/cid/ciy039. No abstract available.

PMID:
29370370
30.

Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells.

Kumaresan PR, da Silva TA, Kontoyiannis DP.

Front Immunol. 2018 Jan 8;8:1939. doi: 10.3389/fimmu.2017.01939. eCollection 2017. Review.

31.

Guidelines and recommendations on yeast cell death nomenclature.

Carmona-Gutierrez D, Bauer MA, Zimmermann A, Aguilera A, Austriaco N, Ayscough K, Balzan R, Bar-Nun S, Barrientos A, Belenky P, Blondel M, Braun RJ, Breitenbach M, Burhans WC, Büttner S, Cavalieri D, Chang M, Cooper KF, Côrte-Real M, Costa V, Cullin C, Dawes I, Dengjel J, Dickman MB, Eisenberg T, Fahrenkrog B, Fasel N, Fröhlich KU, Gargouri A, Giannattasio S, Goffrini P, Gourlay CW, Grant CM, Greenwood MT, Guaragnella N, Heger T, Heinisch J, Herker E, Herrmann JM, Hofer S, Jiménez-Ruiz A, Jungwirth H, Kainz K, Kontoyiannis DP, Ludovico P, Manon S, Martegani E, Mazzoni C, Megeney LA, Meisinger C, Nielsen J, Nyström T, Osiewacz HD, Outeiro TF, Park HO, Pendl T, Petranovic D, Picot S, Polčic P, Powers T, Ramsdale M, Rinnerthaler M, Rockenfeller P, Ruckenstuhl C, Schaffrath R, Segovia M, Severin FF, Sharon A, Sigrist SJ, Sommer-Ruck C, Sousa MJ, Thevelein JM, Thevissen K, Titorenko V, Toledano MB, Tuite M, Vögtle FN, Westermann B, Winderickx J, Wissing S, Wölfl S, Zhang ZJ, Zhao RY, Zhou B, Galluzzi L, Kroemer G, Madeo F.

Microb Cell. 2018 Jan 1;5(1):4-31. doi: 10.15698/mic2018.01.607. Review.

32.
33.

Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions.

Tatara AM, Kontoyiannis DP, Mikos AG.

Adv Drug Deliv Rev. 2018 Apr;129:319-329. doi: 10.1016/j.addr.2017.12.001. Epub 2017 Dec 6. Review.

PMID:
29221962
34.

Checkpoint inhibitors and aspergillosis in AML: the double hit hypothesis.

Daver N, Kontoyiannis DP.

Lancet Oncol. 2017 Dec;18(12):1571-1573. doi: 10.1016/S1470-2045(17)30852-5. No abstract available.

PMID:
29208429
35.

Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.

Kontoyiannis DP, Selleslag D, Mullane K, Cornely OA, Hope W, Lortholary O, Croos-Dabrera R, Lademacher C, Engelhardt M, Patterson TF.

J Antimicrob Chemother. 2018 Mar 1;73(3):757-763. doi: 10.1093/jac/dkx423.

PMID:
29194488
36.

Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer.

Sagiv O, Thakar SD, Kandl TJ, Kontoyiannis DP, Debnam JM, Esmaeli B.

Ophthalmology. 2018 Feb;125(2):318-320. doi: 10.1016/j.ophtha.2017.10.006. Epub 2017 Nov 8. Review. No abstract available.

PMID:
29128228
37.

Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels.

Foolad F, Kontoyiannis DP.

J Antimicrob Chemother. 2018 Jan 1;73(1):256-258. doi: 10.1093/jac/dkx362. No abstract available.

PMID:
29121264
38.

Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.

Chamilos G, Lionakis MS, Kontoyiannis DP.

Clin Infect Dis. 2018 Jan 6;66(1):140-148. doi: 10.1093/cid/cix687.

39.

Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often.

Economides MP, Ballester LY, Kumar VA, Jiang Y, Tarrand J, Prieto V, Torres HA, Kontoyiannis DP.

J Infect. 2017 Dec;75(6):572-580. doi: 10.1016/j.jinf.2017.09.011. Epub 2017 Sep 14.

PMID:
28919347
40.

Acute myeloid leukemia and the infectious diseases consultant.

Mulanovich V, Kontoyiannis DP.

Leuk Lymphoma. 2018 Jun;59(6):1284-1291. doi: 10.1080/10428194.2017.1365861. Epub 2017 Sep 15. Review.

PMID:
28914100
41.

Antifungal Resistance: An Emerging Reality and A Global Challenge.

Kontoyiannis DP.

J Infect Dis. 2017 Aug 15;216(suppl_3):S431-S435. doi: 10.1093/infdis/jix179. No abstract available.

PMID:
28911044
42.

Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.

McCarthy MW, Kontoyiannis DP, Cornely OA, Perfect JR, Walsh TJ.

J Infect Dis. 2017 Aug 15;216(suppl_3):S474-S483. doi: 10.1093/infdis/jix130. Review.

PMID:
28911042
43.

Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management.

Farmakiotis D, Kontoyiannis DP.

Int J Antimicrob Agents. 2017 Sep;50(3):318-324. doi: 10.1016/j.ijantimicag.2017.05.019. Epub 2017 Jun 29. Review.

PMID:
28669831
44.

Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.

Kontoyiannis DP, Bassetti M, Nucci M, Capparella MR, Yan JL, Aram J, Hogan PA.

Mycoses. 2017 Oct;60(10):663-667. doi: 10.1111/myc.12641. Epub 2017 Jun 9.

PMID:
28597967
45.

Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?

Le A, Farmakiotis D, Tarrand JJ, Kontoyiannis DP.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00631-17. doi: 10.1128/AAC.00631-17. Print 2017 Aug.

46.

Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses.

Tverdek FP, Heo ST, Aitken SL, Granwehr B, Kontoyiannis DP.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00188-17. doi: 10.1128/AAC.00188-17. Print 2017 Aug.

47.

Synthesis and Characterization of Diol-Based Unsaturated Polyesters: Poly(diol fumarate) and Poly(diol fumarate-co-succinate).

Tatara AM, Watson E, Satish T, Scott DW, Kontoyiannis DP, Engel PS, Mikos AG.

Biomacromolecules. 2017 Jun 12;18(6):1724-1735. doi: 10.1021/acs.biomac.7b00044. Epub 2017 May 17.

PMID:
28486802
48.

Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib.

Messina JA, Maziarz EK, Spec A, Kontoyiannis DP, Perfect JR.

Open Forum Infect Dis. 2017 Feb 9;4(1):ofw261. doi: 10.1093/ofid/ofw261. eCollection 2017 Winter.

49.

The quinoline bromoquinol exhibits broad-spectrum antifungal activity and induces oxidative stress and apoptosis in Aspergillus fumigatus.

Ben Yaakov D, Shadkchan Y, Albert N, Kontoyiannis DP, Osherov N.

J Antimicrob Chemother. 2017 Aug 1;72(8):2263-2272. doi: 10.1093/jac/dkx117.

PMID:
28475687
50.

A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.

Risslegger B, Zoran T, Lackner M, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Houbraken J, Uzun O, Edlinger M, Fuente S, Lass-Flörl C.

Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13.

Supplemental Content

Loading ...
Support Center